Cheap fluid may shield heart better during surgery
NCT ID NCT06414330
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested two different solutions used to protect the heart during bypass surgery. One is a modified version of a common fluid (Ringer acetate), the other is a standard solution (HTK). Researchers checked which one led to fewer abnormal heart rhythms and less heart muscle damage after surgery. 124 adults having coronary bypass surgery took part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ringer acetate based modified Del Nido cardioplegia solution
- What this could lead to
- If it works, this could show that a cheaper, widely available fluid protects the heart better during surgery, reducing complications.
- What could go wrong
- This is a small, completed trial with 124 patients, so results may not apply to all heart surgeries. The benefit over standard care may be small or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut university, faculty of medicine, anesthesia and ICU and pain management department
Asyut, Asyut Governorate, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.